Alagille syndrome

ICD-10 Codes

Related ICD-10:

Description

Alagille syndrome is a rare genetic disorder that affects multiple organ systems in the body, including the liver, heart, eyes, face, skeleton, blood vessels, and kidneys [2]. It is an autosomal dominant disease, meaning that a child can inherit the condition by inheriting a gene mutation from only one parent [7].

The symptoms of Alagille syndrome can vary widely among affected individuals, but common signs include:

  • Persistent jaundice (yellowing of the skin and eyes)
  • Severe itchiness
  • Fatty deposits in the skin (xanthomas)
  • Dark urine or gray or white stools

In addition to these symptoms, Alagille syndrome can also affect other parts of the body, including the heart, eyes, bones, kidneys, and nervous system [9].

The genetic cause of Alagille syndrome is often related to changes in a gene called Jagged1 located on chromosome 20. In some cases, the entire gene may be deleted [3]. This rare disorder can have significant implications for affected individuals and their families.

It's worth noting that Alagille syndrome closely resembles other forms of liver disease seen in infants and young children [6], making accurate diagnosis crucial for proper treatment and management.

Additional Characteristics

  • Severe itchiness
  • Persistent jaundice (yellowing of the skin and eyes)
  • Fatty deposits in the skin (xanthomas)
  • Dark urine or gray or white stools

Signs and Symptoms

Alagille syndrome is a rare genetic disorder that affects the liver, heart, and other organs. The signs and symptoms of this condition can vary from person to person, but here are some common features:

  • Jaundice: A yellowish tinge in the skin and the whites of the eyes, which is usually present at birth [1][2].
  • Severe itching: Itchiness of the skin, also known as pruritus, can be a severe symptom of Alagille syndrome [3][4].
  • Fatty deposits in the skin: Xanthomas, or fatty deposits, can appear on the skin, particularly on the palms and soles [5][6].
  • Dark urine or gray/white stools: The liver damage caused by Alagille syndrome can lead to dark-colored urine and pale, loose, or clay-colored stools [7][8].

In addition to these symptoms, people with Alagille syndrome may also experience poor growth within the first three months of life, followed by persistent jaundice later on [8]. In some cases, the disease is caused by a new gene mutation that is not inherited from a parent, which can lead to similar liver signs and symptoms [9].

It's worth noting that these symptoms can vary in severity and may not be present in all individuals with Alagille syndrome. If you or someone you know has been diagnosed with this condition, it's essential to work closely with a healthcare provider to manage the symptoms and develop a treatment plan.

References: [1] Context result 1 [2] Context result 2 [3] Context result 4 [4] Context result 6 [5] Context result 5 [6] Context result 6 [7] Context result 7 [8] Context result 8 [9] Context result 9

Additional Symptoms

Diagnostic Tests

Alagille syndrome can be diagnosed through various diagnostic tests, which are essential for confirming the presence of this genetic disorder.

Blood Tests: Blood tests may be used to check for signs of liver damage and other health problems related to Alagille syndrome. These tests include: * ALT (alanine transaminase) * AST (aspartate transaminase) * GGT (gamma-glutamyl transferase) * Albumin * Bilirubin * Conjugated bilirubin * PT/PTT (prothrombin time and partial thromboplastin time)

These tests can help identify liver damage, which is a common symptom of Alagille syndrome [3].

Liver Biopsy: A liver biopsy is a crucial diagnostic test for Alagille syndrome. It involves taking a small sample of liver tissue to examine under a microscope. The biopsy can show fewer bile ducts than normal and at least three of the following symptoms: * Face shape abnormalities * Heart problems * Eye problems * Skeletal deformities

A liver biopsy is considered definitive for diagnosing Alagille syndrome [2].

Genetic Testing: Genetic testing, specifically chromosomal analysis, can confirm a diagnosis of Alagille syndrome by identifying mutations in the JAG1 gene (20p12) [4]. This test uses next-generation sequencing to detect single nucleotide, small deletion-insertion, and copy number variants in two genes (JAG1 and NOTCH2).

Other Diagnostic Tests: Other diagnostic tests may include: * Urinalysis * Eye exam * X-ray of the spine * Heart exam

These tests can help identify other symptoms associated with Alagille syndrome [5].

In summary, a diagnosis of Alagille syndrome is confirmed by a combination of clinical signs and symptoms, medical history, physical examination, eye examination, and diagnostic testing. The specific diagnostic tests used may vary depending on the individual case.

References: [1] Not mentioned in context [2] Context #2 [3] Context #3 [4] Context #4 [5] Context #5

Additional Diagnostic Tests

  • Genetic testing
  • Urinalysis
  • Liver biopsy
  • Eye exam
  • Albumin
  • Bilirubin
  • ALT (alanine transaminase)
  • AST (aspartate transaminase)
  • GGT (gamma-glutamyl transferase)
  • Conjugated bilirubin
  • PTT (prothrombin time and partial thromboplastin time)
  • X-ray of the spine
  • Heart exam

Treatment

Treatment Options for Alagille Syndrome

Alagille syndrome, a rare genetic disorder, requires comprehensive treatment to manage its symptoms and prevent life-threatening complications. While there is no cure for the condition, various drug treatments have been approved by the U.S. Food and Drug Administration (FDA) to alleviate its effects.

Approved Medications

Two FDA-approved medications are available to treat cholestatic pruritus associated with Alagille syndrome:

  • Livmarli (Maralixibat): This medication works by inhibiting the ileal bile acid transporter, which helps increase bile flow from the liver. It was approved in 2021 for patients with Alagille syndrome.
  • Bylvay (Odevixibat): Another FDA-approved medication, Bylvay, also targets cholestatic pruritus associated with Alagille syndrome by inhibiting the ileal bile acid transporter.

Other Treatment Options

In addition to these medications, treatment for Alagille syndrome focuses on:

  • Increasing bile flow from the liver
  • Maintaining normal growth and development patterns in children
  • Managing symptoms to provide comfort and prevent life-threatening complications

According to a study published in 2023, maralixibat is the first FDA-approved drug for treating cholestatic pruritus in children with Alagille syndrome [8]. Another study from 2022 highlights that there is no cure for Alagille syndrome, but treatment can manage symptoms and prevent life-threatening complications [6].

References

[1] Context result 4 [2] Context result 5 [3] Context result 7 [4] Context result 8 [5] Context result 9

Recommended Medications

  • Livmarli (Maralixibat)
  • Bylvay (Odevixibat)

๐Ÿ’Š Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Alagille syndrome, a rare genetic disorder, has several differential diagnoses that need to be considered for accurate diagnosis. Here are some of the conditions that may present similarly to Alagille syndrome:

  • Biliary atresia: This is a condition where there is a blockage or absence of bile ducts in the liver, leading to jaundice and other complications [1]. Like Alagille syndrome, biliary atresia can cause chronic cholestasis and liver dysfunction.
  • Congenital hepatic fibrosis: This is a rare condition characterized by scarring of the liver tissue, which can lead to liver dysfunction and other symptoms similar to those seen in Alagille syndrome [1].
  • Cystic fibrosis: While not directly related to liver function, cystic fibrosis can cause chronic respiratory problems and malnutrition, which may be mistaken for some symptoms of Alagille syndrome [2].
  • Neonatal jaundice: This is a condition where newborns have high levels of bilirubin in their blood, leading to yellowing of the skin and eyes. While not directly related to Alagille syndrome, neonatal jaundice can be a differential diagnosis for some cases [1].

It's essential to note that these conditions may present with similar symptoms, but they require distinct diagnostic approaches. A thorough medical evaluation, including genetic testing, liver biopsy, and other diagnostic tools, is necessary to confirm the diagnosis of Alagille syndrome.

References: [1] Context 1: Jul 1, 2021 โ€” The differential diagnoses of Alagille syndrome include biliary atresia, congenital hepatic fibrosis, cystic fibrosis, neonatal jaundice, ... [2] Context 5: by PD Turnpenny ยท 2012 ยท Cited by 484 โ€” The diagnosis is essentially clinical, dominated by the consequences of bile duct paucity โ€“ chronic cholestasis โ€“ and congenital heart disease.

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_13605
owl#annotatedSource
t456607
oboInOwl#hasOBONamespace
disease_ontology
rdf-schema#comment
OMIM mapping confirmed by DO. [SN].
oboInOwl#id
DOID:9245
core#notation
DOID:9245
oboInOwl#hasDbXref
UMLS_CUI:C0085280
core#exactMatch
MESH:D016738
IAO_0000115
A liver disease that is characterized by an accumulation of bile in the liver resulting from a reducted number of liver small bile ducts.
rdf-schema#label
Alagille syndrome
oboInOwl#hasExactSynonym
Arteriohepatic dysplasia
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_409
relatedICD
http://example.org/icd10/Q44.7
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.